/
No Comments
Crisil expects pharmaceutical sector revenue to grow 11–13% this fiscal year, led by exports and domestic demand.
Crisil expects pharmaceutical sector revenue to grow 11–13% this fiscal year, led by exports and domestic demand.
US plan to impose a 100% tariff on imported generic medicines from 2028 raises concerns for Indian drugmakers, but the industry says it has time to adapt. Highlights Story India’s pharmaceutical industry is closely monitoring the US administration’s proposal to impose a 100% tariff on imported generic medicines from 2028....
India Business & Trade is a national media platform decoding the ideas, decisions and shifts shaping India’s growth story—across plicy, business, global commerce and a rapidly evolving marketplace.
India Business & Trade
M-62, Saket, New Delhi-110064, India
Stay ahead in the dynamic world of trade and commerce with India Business & Trade’s weekly newsletter.
Copyright © 2026 India Business & Trade. All Rights Reserved
